Director/PDMR Shareholding

RNS Number : 5244W

GlaxoSmithKline PLC

31 January 2012

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests of the under-mentioned Person Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc ("Ordinary shares"):

Dr P J T Vallance

Following the vesting on 29 January 2012 of 25% of an award made on 29 January 2007 under the GlaxoSmithKline Deferred Investment Award Plan ("The Plan"), Dr Vallance will receive a cash payment of 1433.25p per share in respect of 4703.976 notional Ordinary shares on 20 February 2012.

The Company and the above-mentioned person were advised of this information by the Administrators of the Plan on 31 January 2012.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

31 January 2012

 

END

 

 

RDSQFLFXLFFXBBZ